Showing 2,321 - 2,340 results of 24,535 for search 'LiveAD~', query time: 5.63s Refine Results
  1. 2321
  2. 2322

    Serological Profile of Anti-<i>Toxoplasma gondii</i> Antibodies in Liver Transplant Recipients by Gabriella Beltrame Pintos, Francielly Camilla Bazílio Laurindo Pires, Nathália Zini, Rita Cássia Martins Alves da Silva, Francisco Inaldo Mendes Silva Junior, Renato Ferreira da Silva, Tainara Souza Pinho, Luiz Carlos de Mattos, Cinara Cássia Brandão

    Published 2025-01-01
    “…The goal of this study was to evaluate the demographic, clinical, epidemiological, and anti-<i>T. gondii</i> antibody profiles in liver transplant recipients. All demographic, clinical, epidemiological, and serological data were obtained from the electronic medical records of liver transplant recipients from the Liver Transplantation Service of the Hospital de Base in São José do Rio Preto, Brazil, from 2008 to 2018. …”
    Get full text
    Article
  3. 2323

    Incidental Vascular Lesion in Explanted Liver: A Rare Case Report and Review of the Literature by Rossana Kazemimood, Shohreh Eliaszadeh, Kenneth Wind

    Published 2023-01-01
    “…Here we present a case of a 66-year-old male with HSVN who was discovered to have a lesion presenting as a small nodule in an explanted liver. HSVN is a recently described hepatic vascular lesion that has been previously underdiagnosed. …”
    Get full text
    Article
  4. 2324
  5. 2325
  6. 2326

    Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur” by Abdulrahman Ismaiel, Stefan-Lucian Popa, Dan L. Dumitrascu

    Published 2020-01-01
    “…Both nonalcoholic fatty liver disease (NAFLD) and ischemic heart disease have common pathogenic links. …”
    Get full text
    Article
  7. 2327
  8. 2328
  9. 2329

    Abnormal ac4C modification in metabolic dysfunction associated steatotic liver cells by Xiqian Zhang, Yaxian Zheng, Jing Yang, Yan Yang, Qin He, Min Xu, Fangyi Long, Yujie Yang

    Published 2025-01-01
    “…Abstract The pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear due to the complexity of its etiology. …”
    Get full text
    Article
  10. 2330
  11. 2331
  12. 2332

    Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis by Stefania Bruno, Maria Beatriz Herrera Sanchez, Chiara Pasquino, Marta Tapparo, Massimo Cedrino, Ciro Tetta, Giovanni Camussi

    Published 2019-01-01
    “…Cell therapy may be regarded as a feasible alternative to whole organ transplantation to treat end-stage liver diseases. Human liver stem cells (HLSCs) are a population of cells easily obtainable and expandable from a human adult liver biopsy. …”
    Get full text
    Article
  13. 2333
  14. 2334
  15. 2335
  16. 2336
  17. 2337

    Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis C by Juan Wang, Pingwei Zhao, Hui Guo, Xiguang Sun, Zhenyu Jiang, Lijun Xu, Junyan Feng, Junqi Niu, Yanfang Jiang

    Published 2012-01-01
    “…These data suggest that IL-33 may be a pathogenic factor contributing to CHC-related liver injury.…”
    Get full text
    Article
  18. 2338
  19. 2339
  20. 2340